Kasabach-Merritt syndrome and interferon alpha: still a controversial issue.
Biban
P
P
D018206:Angiolipoma / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002675:Child, Preschool; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D011994:Recombinant Proteins; D013577:Syndrome; D013921:Thrombocytopenia / Q000188:drug therapy*
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins